7 articles, transcripts, and reports
AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett — Vice President Global Head of Investor Relations Pascal Soriot — Executive Director and…
AstraZeneca PLC (NYSE: AZN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Andy Barnett — Head of Investor Relations Pascal Soriot — Executive Director and Chief Executive…
AstraZeneca PLC (NYSE: AZN) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Chris Sheldon — Head of Investor Relations Pascal Soriot — Executive Director and Chief Executive…
AstraZeneca PLC (NYSE: AZN) Q4 2020 earnings call dated Feb. 11, 2021 Corporate Participants: Pascal Soriot — Chief Executive Officer David Fredrickson — Executive Vice-President, Oncology Business Unit Ruud…
AstraZeneca PLC (NYSE: AZN) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Pascal Soriot — Executive Director and Chief Executive Officer Dave Fredrickson — Executive Vice President,…
— AstraZeneca (NYSE: AZN) reported fourth quarter 2019 earnings of $0.24 per share and core earnings of $0.89 per share. — Revenue rose 8% to…
— AstraZeneca Plc (NYSE: AZN) reported its third-quarter 2019 earnings of $0.23 per share and core earnings of $0.99 per share. This is compared to…
